Anti-ZO3/ TJP3/ ZO-3 monoclonal antibody

Anti-ZO3/ TJP3/ ZO-3 antibody for FACS & in-vivo assay

Target products collectionGo to TJP3/TJP3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2355-Ab-1/ GM-Tg-hg-MP2355-Ab-2Anti-Human TJP3 monoclonal antibodyHuman
GM-Tg-rg-MP2355-Ab-1/ GM-Tg-rg-MP2355-Ab-2Anti-Rat TJP3 monoclonal antibodyRat
GM-Tg-mg-MP2355-Ab-1/ GM-Tg-mg-MP2355-Ab-2Anti-Mouse TJP3 monoclonal antibodyMouse
GM-Tg-cynog-MP2355-Ab-1/ GM-Tg-cynog-MP2355-Ab-2Anti-Cynomolgus/ Rhesus macaque TJP3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2355-Ab-1/ GM-Tg-felg-MP2355-Ab-2Anti-Feline TJP3 monoclonal antibodyFeline
GM-Tg-cang-MP2355-Ab-1/ GM-Tg-cang-MP2355-Ab-2Anti-Canine TJP3 monoclonal antibodyCanine
GM-Tg-bovg-MP2355-Ab-1/ GM-Tg-bovg-MP2355-Ab-2Anti-Bovine TJP3 monoclonal antibodyBovine
GM-Tg-equg-MP2355-Ab-1/ GM-Tg-equg-MP2355-Ab-2Anti-Equine TJP3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2355-Ab-1/ GM-Tg-hg-MP2355-Ab-2; GM-Tg-rg-MP2355-Ab-1/ GM-Tg-rg-MP2355-Ab-2;
GM-Tg-mg-MP2355-Ab-1/ GM-Tg-mg-MP2355-Ab-2; GM-Tg-cynog-MP2355-Ab-1/ GM-Tg-cynog-MP2355-Ab-2;
GM-Tg-felg-MP2355-Ab-1/ GM-Tg-felg-MP2355-Ab-2; GM-Tg-cang-MP2355-Ab-1/ GM-Tg-cang-MP2355-Ab-2;
GM-Tg-bovg-MP2355-Ab-1/ GM-Tg-bovg-MP2355-Ab-2; GM-Tg-equg-MP2355-Ab-1/ GM-Tg-equg-MP2355-Ab-2
Products NameAnti-TJP3 monoclonal antibody
Formatmab
Target NameTJP3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TJP3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ZO3/ TJP3/ ZO-3 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2355
    Target NameTJP3
    Gene ID27134,27375,314640,721760,403852,101098036,407100,100066918
    Gene Symbol and SynonymsTJP3,ZO-3,ZO3
    Uniprot AccessionO95049,O62683
    Uniprot Entry NameZO3_HUMAN,ZO3_CANLF
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000105289
    Target ClassificationN/A

    The target: TJP3, gene name: TJP3, also named as ZO-3, ZO3. The protein encoded by this gene is a member of the membrane-associated guanylate kinase-like (MAGUK) protein family which is characterized by members having multiple PDZ domains, a single SH3 domain, and a single guanylate kinase-like (GUK)-domain. In addition, members of the zonula occludens protein subfamily have an acidic domain, a basic arginine-rich region, and a proline-rich domain. The protein encoded by this gene plays a role in the linkage between the actin cytoskeleton and tight-junctions and also sequesters cyclin D1 at tight junctions during mitosis. Alternative splicing results in multiple transcript variants encoding distinct isoforms. This gene has a partial pseudogene on chromosome 1. [provided by RefSeq, May 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.